因 COVID-19 而暂停乳腺癌筛查：可能出现的情况。
Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.
机构信息
Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.
Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy
出版信息
In Vivo. 2020 Sep-Oct;34(5):3047-3053. doi: 10.21873/invivo.12139.
BACKGROUND/AIM: Coronavirus disease is spreading worldwide. Due to fast transmission and high fatality rate drastic emergency restrictions were issued. During the lockdown, only urgent medical services are guaranteed. All non-urgent services, as breast cancer (BC) screening, are temporarily suspended. The potential of breast cancer screening programs in increasing the survival rate and decreasing the mortality rate has been widely confirmed. Suspension could lead to worse outcomes for breast cancer patients. Our study aimed to analyse the data and provide estimates regarding the temporary BC screening suspension.
PATIENTS AND METHODS
Data regarding breast cancer and respective screening programs were achieved through literature research and analysis.
RESULTS
Considering three different scenarios with respect to the lockdown's impact on breast cancer screening, we estimate that approximately 10,000 patients could have a missed diagnosis during these 3 months. Considering a 6-month period, as suggested by the Imperial college model, the number of patients who will not receive a diagnosis will rise to 16,000.
CONCLUSION
Breast cancer screening should be resumed as soon as possible in order to avoid further breast cancer missed diagnosis and reduce the impact of delayed diagnosis.
背景/目的：冠状病毒病正在全球范围内传播。由于传播速度快、死亡率高，因此发布了紧急限制措施。在封锁期间，仅保证紧急医疗服务。所有非紧急服务，如乳腺癌（BC）筛查，都被暂时暂停。乳腺癌筛查计划在提高生存率和降低死亡率方面的潜力已得到广泛证实。暂停可能会导致乳腺癌患者的预后更差。我们的研究旨在分析数据并对临时 BC 筛查暂停提供估计。
患者和方法
通过文献研究和分析获得了有关乳腺癌和相应筛查计划的数据。
结果
考虑到封锁对乳腺癌筛查的三种不同影响情况，我们估计在这 3 个月期间可能会有大约 10000 名患者漏诊。考虑到帝国学院模型建议的 6 个月的时间段，将有 16000 名患者无法得到诊断。
结论
为了避免进一步的乳腺癌漏诊并减轻诊断延误的影响，应尽快恢复乳腺癌筛查。
Zotero 插件